Mitchell Billing

Mitchell Billing is a Managing Director at Chapman Associates, one of the longer-established middle-market M&A advisory firms in the United States (founded in 1954, with more than 2,400 completed transactions). Chapman advises owners and buyers of privately held companies — typically businesses with revenues in the range of roughly $5 million to $150 million — on sell-side and buy-side transactions, working on a largely success-fee basis with no upfront fees. Billing operates out of the Tampa, Florida area.

According to his LinkedIn profile and aggregated professional records, Billing holds a Bachelor of Arts from the State University of New York at Stony Brook and a master's degree from the Graduate School of Business at the University of Wisconsin–Madison. His career prior to M&A advisory includes senior operating roles in healthcare services organizations, including Cardiovascular Provider Resources, American Ophthalmic, and National Emergency Services — a background that lends itself to advising owners of healthcare and services businesses on transactions.

A note on classification: the source stub lists Billing under "Angel Investors" with a seed-round focus, but the verifiable public record describes him primarily as an M&A managing director rather than as an active angel or venture investor. He has also been associated in some listings with capital-raising/advisory activity (referenced as European American Capital), but this could not be confirmed against a primary source. No specific personal angel investments or venture rounds could be verified.

*(No first-person investment thesis statement from Billing himself could be located in public sources.)*

• Primary role is transactional advisory, not venture check-writing: Chapman Associates helps business owners, buyers, and investors "navigate middle-market transactions" — sell-side sales, acquisitions, and related advisory — rather than deploying seed capital into startups.
• Deal size (advisory): Chapman's stated focus is companies with revenues of roughly $5M–$150M, with capacity for larger deals; there is no verified personal angel "check size."
• Sector orientation: Information Technology and other established middle-market verticals, plus Billing's operational depth in healthcare services (cardiovascular, ophthalmic, and emergency medical services).
• Engagement model: "Typically success-based with no upfront fees," reflecting an advisory rather than an equity-investing posture.